Development and Validation of a Highly Sensitive HPLC Method for Determination of Paclitaxel in Pharmaceutical Dosage forms and Biological Samples

ISSN: 1875-676X (Online)
ISSN: 1573-4129 (Print)


Volume 10, 4 Issues, 2014


Download PDF Flyer




Current Pharmaceutical Analysis

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK
Email: cpa@benthamscience.org

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 0.771
5 - Year: 1.107

Development and Validation of a Highly Sensitive HPLC Method for Determination of Paclitaxel in Pharmaceutical Dosage forms and Biological Samples

Author(s): Ezequiel Bernabeu, Sabrina Flor, Christian Hocht, Carlos Taira, Diego Chiappetta, Valeria Tripodi and Silvia Lucangioli

Affiliation: Department of Pharmaceutical Technology, Faculty of Pharmacy and Biochemistry, Universidad of Buenos Aires, Buenos Aires, Argentina. CONICET.

Abstract

A new simple and highly sensitive HPLC-UV method for the analysis of paclitaxel in Taxol® and Abraxane® has been developed which also allows the quantification in biological samples of pharmacokimnetic studies with a very easy sample preparation. The proposed method has advantages over previously reported methods, such as an increase in sensitivity up to 20 times, good accuracy in terms of recovery that allows to work without addition of internal standard and a simple sample preparation in one step.

The analysis was carried out using a Zorbax Eclipse XDB-C18 (4.6 × 150 mm, 3.5 μm) with a column guard. The mobile phase consisted of acetonitrile: water (50: 50) and the flow rate was 1 mL/min, the detection wavelength was 227 nm, the injection volume 5 μL and the analysis was performed at room temperature.

The method was validated according ICH guidelines and FDA guidelines for validation of bioanalytical methods. Linearity was evaluated in the range from 0.005 – 50.0 μg/mL, with a regression coefficient (R2) of 0.9967. LOD and LOQ were 0.001 and 0.005 μg/mL respectively.





Keywords: Paclitaxel, HPLC-UV detection, pharmaceutical formulation, pharmacokinetic studies, validation.

Purchase Online Rights and Permissions

  
  



Article Details

Volume: 10
Issue Number: 3
First Page: 185
Last Page: 192
Page Count: 8
DOI: 10.2174/1573412910666140409002944
Advertisement

Related Journals


Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science